LT-02
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LT-02, covering 2011-11-16 to 2017-06-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) [Phase 3]